Gene: ZNF16
Official Full Name: zinc finger protein 16provided by HGNC
Gene Summary: The protein encoded by this gene contains multiple tandem zinc finger motifs. The encoded protein is involved in the differentiation of erythroid and megakaryocytic cells. This gene is located in a cluster of related genes on chromosome 8 encoding zinc finger proteins. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34756 | ZNF16 Knockout cell line (HeLa) | Human | ZNF16 | 1:3~1:6 | Negative | Online Inquiry |
KO34757 | ZNF16 Knockout cell line (HCT 116) | Human | ZNF16 | 1:2~1:4 | Negative | Online Inquiry |
KO34758 | ZNF16 Knockout cell line (HEK293) | Human | ZNF16 | 1:3~1:6 | Negative | Online Inquiry |
KO34759 | ZNF16 Knockout cell line (A549) | Human | ZNF16 | 1:3~1:4 | Negative | Online Inquiry |
ZNF16 Gene Knockout Cell Lines are specially engineered cellular models that facilitate the investigation of the ZNF16 gene's role in various biological processes. By employing CRISPR-Cas9 technology, these cell lines have been generated to disrupt the ZNF16 gene, effectively silencing its expression and allowing researchers to explore the functional consequences of this regulatory gene on cellular behavior.
The primary function of the ZNF16 Gene Knockout Cell Lines is to provide a controlled environment for studies focused on gene expression, signaling pathways, and cellular responses. By knocking out ZNF16, scientists can assess its influence on critical cellular functions such as proliferation, differentiation, and apoptosis. The mechanistic insights gained from these studies are crucial for understanding diseases related to dysregulated gene expression, including cancer and neurodegenerative disorders.
The scientific significance of ZNF16 knockout models lies in their application in basic research as well as clinical settings. They serve as powerful tools for drug development, biomarker discovery, and understanding the pathophysiology of diseases associated with abnormal ZNF16 activity. Their utilization can enhance the development of targeted therapies that may ultimately benefit patient outcomes.
What sets our ZNF16 Gene Knockout Cell Lines apart from alternative models is their superior specificity and the validated efficiency of the gene knockout, which ensures high-quality data generation. Unlike traditional RNA interference methods that can yield off-target effects, our CRISPR-based approach offers a robust, permanent, and precise gene disruption.
For researchers and clinicians seeking to unravel the complexities of gene function, these cell lines provide an unparalleled resource. The ability to conduct experiments with a high degree of confidence in the results accelerates scientific discovery and drives innovations in treatment strategies.
Our company prides itself on its commitment to advancing biological research through high-quality genetic tools. With a focus on precision and reliability, our product offerings empower scientists to transform their research and clinical practice by unlocking the potential of gene regulation analysis.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.